Binance US stock observation on the first day: Indigenous investors in the cryptocurrency industry prefer nano stocks, attracting 600 million trading volume and encountering "unlimited issuance" BlockBeats News: On June 2nd, according to market data, on the first day of Binance's US stock trading, a total of 11 US stocks had trading volumes exceeding $100 million, including: Woke Healthcare (WOK): $394 million, Virgin Galactic (SPCE): $287 million, Nvidia (NVDA): $215 million, Zhongchao Medical (ZCMD): $212 million, Nokia (NOK): $174 million, Intel (INTC): $136 million, Sphere 3D (ANY): $128 million, Optimal (OPTU): $125 million, AMC Entertainment (AMC): $117 million, HPE: $116 million, Abi TS (ABTS): Many stocks on the $104 million list belong to small cap stocks, micro stocks, and even nano stocks. Among them, Sphere 3D has a market value of only 17.06 million US dollars, up 28.11% after market hours; The market value of ABTS is only 6.3484 million yuan, with a 40% increase in the US stock market after closing; These two nano stocks had previously maintained a low trend for a long time, and only began to show abnormal movements after the launch of Binance for US stock trading, and even after the US stock market closed. It is worth noting that the extreme abnormal trading behavior of two nano stocks, WOK and ZCMD, with market values of $197200 and $295400 respectively, has attracted market attention. Taking Wok Healthcare (WOK) as an example, cryptocurrency traders traded nano stocks using the Meme trading strategy, attempting to "violently pull the market" after buying enough chips. Although this led to a short-term increase of 70% in the stock price, it ultimately fell back to its original point. It is reported that Wok Medical (WOK) is a medical consumables manufacturer headquartered in Hangzhou, China (established in 2022 and IPO in August 2024). The company continues to suffer losses and its fundamentals are not optimistic. In order to ensure that it is not delisted due to long-term low stock prices, WOK Medical has conducted two consecutive 1:100 reverse splits in Q4 2025, which is a typical "shell preservation cycle" operation for small cap Chinese concept stocks in the US stock market. The reason why nearly $400 million in trading volume from traders has hit the market, but the stock price has remained almost unchanged is due to the combination of WOK's extremely abundant authorized share capital, SEC Shelf Registration, and ATM (At the Market) plan, which allows the company to "drip" new stocks into the market at any time and flexibly, without having to go through the complete approval process every time. ZCMD also belongs to the "shell type Chinese concept stock", with Shanghai Zhongchao Medical Technology Co., Ltd. as the domestic entity in China, and has strong practical capabilities for "almost unlimited issuance". The core weapon is the huge authorized share capital expansion approved by shareholders, existing F-3 shelf registration, and repeated reverse split shell cycles. Unlike WOK's "ATM continuous drip irrigation", ZCMD is a dilution mode of periodic large value/registration issuance+flexible splitting, but the actual operating space is even larger.